SRPK1 Inhibition, As A Way Of Targeting Pro-Angiogenic VEGF-A Production In Ocular Tumours

被引：0
|
作者：
Gammons, Melissa [1 ]
Coupland, Sarah [2 ]
Dick, Andrew [3 ,4 ]
Bates, David [1 ]
机构：
[1] Univ Bristol, Dept Physiol & Pharmacol, Bristol, Avon, England
[2] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[3] Univ Bristol, Sch Clin Sci, Bristol, Avon, England
[4] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
589; melanoma; 744; tumors; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4526
引用
收藏
页数：2
相关论文
共 45 条
  • [11] Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles
    Treps, Lucas
    Perret, Raul
    Edmond, Sebastien
    Ricard, Damien
    Gavard, Julie
    JOURNAL OF EXTRACELLULAR VESICLES, 2017, 6 (01):
  • [12] The splicing of VEGF-A in monocytes from people with neovascular age related macular degeneration (nAMD) and diabetic retinopathy is altered by inhibition of SRPK1 and CLK
    Gao, Yizhuo
    Agrawal, Jyoti
    Amartey, Jason
    Hawtrey, Tom
    Morris, Jonathan
    Amoaku, Winftied M. K.
    Bates, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [13] Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
    Guyot, Melanie
    Hilmi, Caroline
    Ambrosetti, Damien
    Merlano, Marco
    Lo Nigro, Cristiana
    Durivault, Jerome
    Grepin, Renaud
    Pages, Gilles
    ONCOTARGET, 2017, 8 (06) : 9174 - 9188
  • [14] SRPK1 inhibition and modulation of VEGF alternative splicing as a potential therapeutic strategy in prostate cancer
    Mavrou, Athina
    Bates, Dave
    Oltean, Sebastian
    CANCER RESEARCH, 2014, 74 (19)
  • [15] VEGF-A Promotes Both Pro-angiogenic and Neurotrophic Capacities for Nerve Recovery After Compressive Neuropathy in Rats
    Julien Pelletier
    Emilie Roudier
    Pierre Abraham
    Bérengère Fromy
    Jean Louis Saumet
    Olivier Birot
    Dominique Sigaudo-Roussel
    Molecular Neurobiology, 2015, 51 : 240 - 251
  • [16] VEGF-A Promotes Both Pro-angiogenic and Neurotrophic Capacities for Nerve Recovery After Compressive Neuropathy in Rats
    Pelletier, Julien
    Roudier, Emilie
    Abraham, Pierre
    Fromy, Berengere
    Saumet, Jean Louis
    Birot, Olivier
    Sigaudo-Roussel, Dominique
    MOLECULAR NEUROBIOLOGY, 2015, 51 (01) : 240 - 251
  • [17] The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-β-Mediated Conversion to an ILC1-Like Phenotype
    Hawke, Lindsey G.
    Whitford, Mara K. M.
    Ormiston, Mark L.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [18] Targeting pro-angiogenic CXCL chemokines as a new encouraging way to combat prostate cancer
    Mijatovic, Tatjana
    Mahieu, Tina
    De Neve, Nancy
    De Neve, Nancy
    Simon, Gentiane
    Dewelle, Janique
    Van Quaquebeke, Eric
    Darro, Francis
    Kiss, Robert
    CANCER RESEARCH, 2008, 68 (09)
  • [19] SRPK1 Inhibition Modulates VEGF Splicing to Reduce Pathological Neovascularization in a Rat Model of Retinopathy of Prematurity
    Gammons, Melissa V. R.
    Dick, Andrew D.
    Harper, Steven J.
    Bates, David O.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (08) : 5797 - 5806
  • [20] Combinations of pro-angiogenic therapies targeting VEGF and VEGF receptors outperform monotherapies in computational models of human skeletal muscle.
    Mac Gabhann, Feilim
    Popel, Aleksander S.
    FASEB JOURNAL, 2007, 21 (06): : A1214 - A1214
12345